BioTelemetry (BEAT) Tops Q4 EPS by 4c

BioTelemetry (NASDAQ: BEAT) reported Q4 EPS of $0.04, $0.04 better than the analyst estimate of $0.00. Revenue for the quarter came in at $37.2 million versus the consensus estimate of $38.4 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• Chevron (CVX) earnings fall short while revenue tops estimates in Q1
• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• AutoNation (AN) Tops Q1 EPS by 26c